Bull
$380.94
シナリオ価格
$343.750
+4.228 (+1.23%)終値時点
Willis Towers Watson Public Limited Company is a global advisory, brokering and solutions company that provides data-driven, insight-led solutions in the areas of people, risk and capital. Its segments include Health, Wealth & Career (HWC) and Risk & Broking (R&B). The HWC segment provides an array of advice, brokering, solutions and technology for employee benefit plans, institutional investors, compensation and career programs, and the employee experience overall. Its R&B segment provides a range of risk advice, insurance brokerage and consulting services to clients globally, ranging from small businesses to multinational corporations. The segment comprises two primary businesses: its corporate risk and brokering and our insurance consulting and technology businesses. It also specializes in private equity secondaries investing, delivering innovative portfolio construction, risk management, and client solutions. It provides pension and savings products through a mobile application.
Willis Towers Watson PLC (WTW) is a good buy right now due to its current price of $343.75, which is significantly below the average analyst price target of $405 to $455. The stock has shown a positive trend with a 5-day change of +0.51% and a year-to-date change of +5.36%. Additionally, the company has a strong forward P/E ratio of 17.92, indicating it is reasonably priced for future earnings growth. However, a key risk is the recent exit of Baupost Group from its entire stake in WTW, which could signal a lack of confidence among institutional investors.
TD Cowen
$455
2026-08-20
TD Cowen
2026-08-20
目標株価
$455
Morgan Stanley
$350
2026-08-19
Morgan Stanley
2026-08-19
目標株価
$350
UBS
$405
2026-08-03
UBS
2026-08-03
目標株価
$405
Morgan Stanley
$315
2026-08-03
Morgan Stanley
2026-08-03
目標株価
$315
Cantor Fitzgerald
$380
2026-08-03
Cantor Fitzgerald
2026-08-03
目標株価
$380
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Baupost Group Exits Entire Stake in Vaxcyte and WTW

Baupost Group Increases Stakes in Alphabet and Amazon

Baupost Group's Q2 2026 Investment Moves

ETF Component Trading Dynamics on Thursday

WTW Appoints Jayne Bok as Head of Hong Kong and Macau
Willis Towers Watson Public Limited Company is a global advisory, brokering and solutions company that provides data-driven, insight-led solutions in the areas of people, risk and capital. Its segments include Health, Wealth & Career (HWC) and Risk & Broking (R&B). The HWC segment provides an array of advice, brokering, solutions and technology for employee benefit plans, institutional investors, compensation and career programs, and the employee experience overall. Its R&B segment provides a range of risk advice, insurance brokerage and consulting services to clients globally, ranging from small businesses to multinational corporations. The segment comprises two primary businesses: its corporate risk and brokering and our insurance consulting and technology businesses. It also specializes in private equity secondaries investing, delivering innovative portfolio construction, risk management, and client solutions. It provides pension and savings products through a mobile application. It operates in the Financials sector (INSURANCE AGENTS, BROKERS & SERVICE industry).
Willis Towers Watson PLC (WTW) is a good buy right now due to its current price of $343.75, which is significantly below the average analyst price target of $405 to $455. The stock has shown a positive trend with a 5-day change of +0.51% and a year-to-date change of +5.36%. Additionally, the company has a strong forward P/E ratio of 17.92, indicating it is reasonably priced for future earnings growth. However, a key risk is the recent exit of Baupost Group from its entire stake in WTW, which could signal a lack of confidence among institutional investors.
3 analysts cover WTW: 1 rate it Buy, 2 Hold and 0 Sell. The average price target is 365.00.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。